BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Godley LA. Inherited predisposition to acute myeloid leukemia. Semin Hematol 2014;51:306-21. [PMID: 25311743 DOI: 10.1053/j.seminhematol.2014.08.001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Király AP, Kállay K, Gángó A, Kellner Á, Egyed M, Szőke A, Kiss R, Vályi-Nagy I, Csomor J, Matolcsy A, Bödör C. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary. Pathol Oncol Res 2018;24:83-8. [PMID: 28357685 DOI: 10.1007/s12253-017-0216-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Galera P, Dulau-Florea A, Calvo KR. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia. Int J Lab Hematol 2019;41 Suppl 1:131-41. [PMID: 31069978 DOI: 10.1111/ijlh.12999] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
3 Tawana K, Rio-machin A, Preudhomme C, Fitzgibbon J. Familial CEBPA -mutated acute myeloid leukemia. Seminars in Hematology 2017;54:87-93. [DOI: 10.1053/j.seminhematol.2017.04.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
4 Kim N, Choi S, Kim SM, Lee AC, Im K, Park HS, Kim JA, Kim K, Kim I, Chang YH, Lee DS. Monozygotic twins with shared de novo GATA2 mutation but dissimilar phenotypes due to differential promoter methylation. Leuk Lymphoma 2019;60:1053-61. [PMID: 30714451 DOI: 10.1080/10428194.2018.1516039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Samarakkody AS, Shin NY, Cantor AB. Role of RUNX Family Transcription Factors in DNA Damage Response. Mol Cells 2020;43:99-106. [PMID: 32024352 DOI: 10.14348/molcells.2019.0304] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
6 Bellissimo DC, Speck NA. RUNX1 Mutations in Inherited and Sporadic Leukemia. Front Cell Dev Biol 2017;5:111. [PMID: 29326930 DOI: 10.3389/fcell.2017.00111] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
7 Sakurai M, Nannya Y, Yamazaki R, Yamaguchi K, Koda Y, Abe R, Yokoyama K, Ogawa S, Mori T. Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies. Ann Hematol 2021. [PMID: 33462643 DOI: 10.1007/s00277-021-04430-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Goldberg L, Gough SM, Lee F, Dang C, Walker RL, Zhu YJ, Bilke S, Pineda M, Onozawa M, Jo Chung Y, Meltzer PS, Aplan PD. Somatic mutations in murine models of leukemia and lymphoma: Disease specificity and clinical relevance. Genes Chromosomes Cancer 2017;56:472-83. [PMID: 28196408 DOI: 10.1002/gcc.22451] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
9 Estevez B, Borst S, Jarocha D, Sudunagunta V, Gonzalez M, Garifallou J, Hakonarson H, Gao P, Tan K, Liu P, Bagga S, Holdreith N, Tong W, Speck N, French DL, Gadue P, Poncz M. RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells. Blood 2021;137:2662-75. [PMID: 33569577 DOI: 10.1182/blood.2020006389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Babushok DV, Bessler M, Olson TS. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Leuk Lymphoma 2016;57:520-36. [PMID: 26693794 DOI: 10.3109/10428194.2015.1115041] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 9.1] [Reference Citation Analysis]
11 Luo X, Feurstein S, Mohan S, Porter CC, Jackson SA, Keel S, Chicka M, Brown AL, Kesserwan C, Agarwal A, Luo M, Li Z, Ross JE, Baliakas P, Pineda-Alvarez D, DiNardo CD, Bertuch AA, Mehta N, Vulliamy T, Wang Y, Nichols KE, Malcovati L, Walsh MF, Rawlings LH, McWeeney SK, Soulier J, Raimbault A, Routbort MJ, Zhang L, Ryan G, Speck NA, Plon SE, Wu D, Godley LA. ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants. Blood Adv 2019;3:2962-79. [PMID: 31648317 DOI: 10.1182/bloodadvances.2019000644] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 23.0] [Reference Citation Analysis]
12 Sandner AS, Weggel R, Mehraein Y, Schneider S, Hiddemann W, Spiekermann K. Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis. PLoS One 2019;14:e0215453. [PMID: 30998723 DOI: 10.1371/journal.pone.0215453] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
13 Vormittag-Nocito E, Ni H, Schmidt ML, Lindgren V. Thrombocytopenia and Predisposition to Acute Myeloid Leukemia due to Mosaic Ring 21 with Loss of RUNX1: Cytogenetic and Molecular Characterization. Mol Syndromol 2019;9:306-11. [PMID: 30800047 DOI: 10.1159/000494645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Feurstein S, Drazer MW, Godley LA. Genetic predisposition to leukemia and other hematologic malignancies. Seminars in Oncology 2016;43:598-608. [DOI: 10.1053/j.seminoncol.2016.10.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
15 Saida S. Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders. Curr Treat Options in Oncol 2017;18. [DOI: 10.1007/s11864-017-0485-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
16 Brown AL, Churpek JE, Malcovati L, Döhner H, Godley LA. Recognition of familial myeloid neoplasia in adults. Seminars in Hematology 2017;54:60-8. [DOI: 10.1053/j.seminhematol.2016.11.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
17 Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Rev 2019;36:70-87. [PMID: 31101526 DOI: 10.1016/j.blre.2019.04.005] [Cited by in Crossref: 111] [Cited by in F6Publishing: 96] [Article Influence: 37.0] [Reference Citation Analysis]
18 Akpan IJ, Osman AEG, Drazer MW, Godley LA. Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies. Curr Hematol Malig Rep 2018;13:426-34. [DOI: 10.1007/s11899-018-0473-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
19 Hamilton KV, Maese L, Marron JM, Pulsipher MA, Porter CC, Nichols KE. Stopping Leukemia in Its Tracks: Should Preemptive Hematopoietic Stem-Cell Transplantation be Offered to Patients at Increased Genetic Risk for Acute Myeloid Leukemia? JCO 2019;37:2098-104. [DOI: 10.1200/jco.19.00181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 Yokota A, Huo L, Lan F, Wu J, Huang G. The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies. Mol Cells 2020;43:145-52. [PMID: 31964134 DOI: 10.14348/molcells.2019.0252] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Gruszka AM, Valli D, Alcalay M. Understanding the molecular basis of acute myeloid leukemias: where are we now? Int J Hematol Oncol 2017;6:43-53. [PMID: 30302223 DOI: 10.2217/ijh-2017-0002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Kohlmann W, Schiffman JD. Discussing and managing hematologic germ line variants. Hematology Am Soc Hematol Educ Program 2016;2016:309-15. [PMID: 27913496 DOI: 10.1182/asheducation-2016.1.309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
23 Hernandez-Valladares M, Aasebø E, Selheim F, Berven FS, Bruserud Ø. Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid Leukemia. Proteomes 2016;4:E24. [PMID: 28248234 DOI: 10.3390/proteomes4030024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
24 Weinberg OK, Kuo F, Calvo KR. Germline Predisposition to Hematolymphoid Neoplasia. Am J Clin Pathol 2019;152:258-76. [PMID: 31309983 DOI: 10.1093/ajcp/aqz067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
25 Schratz KE, DeZern AE. Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice. Hematol Oncol Clin North Am 2020;34:333-56. [PMID: 32089214 DOI: 10.1016/j.hoc.2019.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 Andrés-Zayas C, Suárez-González J, Rodríguez-Macías G, Dorado N, Osorio S, Font P, Carbonell D, Chicano M, Muñiz P, Bastos M, Kwon M, Díez-Martín JL, Buño I, Martínez-Laperche C. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition. Mol Oncol 2021;15:2273-84. [PMID: 33533142 DOI: 10.1002/1878-0261.12921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 McGee RB, Nichols KE. Introduction to cancer genetic susceptibility syndromes. Hematology Am Soc Hematol Educ Program 2016;2016:293-301. [PMID: 27913494 DOI: 10.1182/asheducation-2016.1.293] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
28 Li R, Sobreira N, Witmer PD, Pratz KW, Braunstein EM. Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia. Haematologica 2016;101:e228-31. [PMID: 26944477 DOI: 10.3324/haematol.2015.139790] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
29 Schlegelberger B, Mecucci C, Wlodarski M. Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies. Fam Cancer 2021. [PMID: 34057692 DOI: 10.1007/s10689-021-00263-z] [Reference Citation Analysis]
30 Kewan T, Noss R, Godley LA, Rogers HJ, Carraway HE. Inherited Thrombocytopenia Caused by Germline ANKRD26 Mutation Should Be Considered in Young Patients With Suspected Myelodysplastic Syndrome. J Investig Med High Impact Case Rep 2020;8:2324709620938941. [PMID: 32618208 DOI: 10.1177/2324709620938941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
31 Klco JM, Mullighan CG. Advances in germline predisposition to acute leukaemias and myeloid neoplasms. Nat Rev Cancer 2021;21:122-37. [PMID: 33328584 DOI: 10.1038/s41568-020-00315-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
32 Crysandt M, Brings K, Beier F, Thiede C, Brümmendorf TH, Jost E. Germ line predisposition to myeloid malignancies appearing in adulthood. Expert Rev Hematol 2018;11:625-36. [PMID: 29958021 DOI: 10.1080/17474086.2018.1494566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Iwafuchi H. The histopathology of bone marrow failure in children. J Clin Exp Hematop 2018;58:68-86. [PMID: 29998978 DOI: 10.3960/jslrt.18018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
34 Baptista RLR, Dos Santos ACE, Gutiyama LM, Solza C, Zalcberg IR. Familial Myelodysplastic/Acute Leukemia Syndromes-Myeloid Neoplasms with Germline Predisposition. Front Oncol 2017;7:206. [PMID: 28955657 DOI: 10.3389/fonc.2017.00206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
35 Churpek JE, Artz A, Bishop M, Liu H, Godley LA. Correspondence Regarding the Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues. Biology of Blood and Marrow Transplantation 2016;22:183-4. [DOI: 10.1016/j.bbmt.2015.10.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
36 Fowles JS, How J, Allen MJ, Oh ST. Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia vera. Leukemia 2019;33:1522-6. [PMID: 30635625 DOI: 10.1038/s41375-018-0349-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Wu X, Deng J, Zhang N, Liu X, Zheng X, Yan T, Ye W, Gong Y. Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09347-0] [Reference Citation Analysis]
38 Koschade SE, Stratmann JA, Miesbach W, Steffen B, Serve H, Finkelmeier F, Brandts CH, Ballo O. Intracranial hemorrhage in newly diagnosed non-promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy. Eur J Haematol 2021. [PMID: 34714547 DOI: 10.1111/ejh.13718] [Reference Citation Analysis]
39 Simon L, Spinella JF, Yao CY, Lavallée VP, Boivin I, Boucher G, Audemard E, Bordeleau ME, Lemieux S, Hébert J, Sauvageau G. High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML. Blood 2020;135:1882-6. [PMID: 32315381 DOI: 10.1182/blood.2019003357] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
40 Kennedy AL, Shimamura A. Genetic predisposition to MDS: clinical features and clonal evolution. Blood 2019;133:1071-85. [PMID: 30670445 DOI: 10.1182/blood-2018-10-844662] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 12.3] [Reference Citation Analysis]
41 Kohlmann W, Schiffman JD. Discussing and managing hematologic germ line variants. Blood 2016;128:2497-503. [DOI: 10.1182/blood-2016-06-716704] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
42 Czuchlewski DR, Peterson LC. Myeloid Neoplasms with Germline Predisposition. Surgical Pathology Clinics 2016;9:165-76. [DOI: 10.1016/j.path.2015.09.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
43 Roloff GW, Drazer MW, Godley LA. Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology. JCO Precis Oncol 2021;5:107-22. [PMID: 34994594 DOI: 10.1200/PO.20.00387] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
44 Martignoles JA, Delhommeau F, Hirsch P. Genetic Hierarchy of Acute Myeloid Leukemia: From Clonal Hematopoiesis to Molecular Residual Disease. Int J Mol Sci 2018;19:E3850. [PMID: 30513905 DOI: 10.3390/ijms19123850] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]